ATE360078T1 - Mannanase aus kaffee - Google Patents

Mannanase aus kaffee

Info

Publication number
ATE360078T1
ATE360078T1 AT01933654T AT01933654T ATE360078T1 AT E360078 T1 ATE360078 T1 AT E360078T1 AT 01933654 T AT01933654 T AT 01933654T AT 01933654 T AT01933654 T AT 01933654T AT E360078 T1 ATE360078 T1 AT E360078T1
Authority
AT
Austria
Prior art keywords
coffee
hydrolysis
polysaccharides
genome
reproduced
Prior art date
Application number
AT01933654T
Other languages
English (en)
Inventor
Pierre Marraccini
John Rogers
Raymond David Pridmore
Christof Gysler
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE360078T1 publication Critical patent/ATE360078T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Tea And Coffee (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01933654T 2000-03-30 2001-02-13 Mannanase aus kaffee ATE360078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00201175A EP1138771A1 (de) 2000-03-30 2000-03-30 Endo-Mannanase aus Kaffee

Publications (1)

Publication Number Publication Date
ATE360078T1 true ATE360078T1 (de) 2007-05-15

Family

ID=8171286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01933654T ATE360078T1 (de) 2000-03-30 2001-02-13 Mannanase aus kaffee

Country Status (9)

Country Link
US (2) US7148399B2 (de)
EP (2) EP1138771A1 (de)
JP (1) JP2003529367A (de)
AT (1) ATE360078T1 (de)
DE (1) DE60127950T2 (de)
DK (1) DK1272642T3 (de)
ES (1) ES2283412T3 (de)
PT (1) PT1272642E (de)
WO (1) WO2001075084A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457821A1 (en) 2001-10-10 2003-04-24 Societe Des Produits Nestle S.A. Coffee plant with reduced .alpha.-d-galactosidase activity
CN102822334A (zh) 2010-03-09 2012-12-12 雀巢产品技术援助有限公司 咖啡中半乳甘露聚糖含量的调节
CN107129958B (zh) * 2017-06-09 2021-07-20 华南理工大学 一种β-甘露聚糖酶工程菌的筛选方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334529A (en) 1989-06-27 1994-08-02 Escagenetics Corporation Stably transformed coffee plant cells and plantlets
US6329191B1 (en) * 1993-08-30 2001-12-11 Hawaii Biotechnology Group, Inc. DNA encoding recombinant coffee bean alpha-galactosidase
JP3043560B2 (ja) * 1993-12-27 2000-05-22 キリンビバレッジ株式会社 安定なコーヒー飲料の製造法
EP0676145B1 (de) * 1994-04-07 1999-09-01 Societe Des Produits Nestle S.A. Hydrolyse von Kaffee mit immobilisierter Beta-Mannanase
US5874269A (en) * 1995-06-07 1999-02-23 University Of Hawaii Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plant
US5778310A (en) 1995-11-30 1998-07-07 Northern Telecom Limited Co-channel interference reduction
GB9524752D0 (en) * 1995-12-04 1996-02-07 Danisco Modification process
CN1183998A (zh) 1997-10-22 1998-06-10 李榕生 紧凑式高效低能耗空气磁力分离技术
AU1016999A (en) * 1997-11-07 1999-05-31 University Of Guelph Cdna clone of endo-beta-mannanase from plant tissues
US6060299A (en) * 1998-06-10 2000-05-09 Novo Nordisk A/S Enzyme exhibiting mannase activity, cleaning compositions, and methods of use
CN101024826B (zh) * 1998-06-10 2014-09-03 诺沃奇梅兹有限公司 新的甘露聚糖酶
EP1123404A2 (de) * 1998-10-13 2001-08-16 Genesis Research & Development Corporation Limited Materialien und verfahren zur modifikation von pflanzenzellpolysacchariden
EP1131446A1 (de) * 1998-11-11 2001-09-12 Societe Des Produits Nestle S.A. Coffea arabica mannanase
EP1033405A3 (de) * 1999-02-25 2001-08-01 Ceres Incorporated DNS-fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide
WO2001023530A1 (en) * 1999-09-30 2001-04-05 The Regents Of The University Of California Genes expressed in germinating seeds and their uses

Also Published As

Publication number Publication date
WO2001075084A3 (en) 2002-01-10
DE60127950T2 (de) 2008-01-17
US7700358B2 (en) 2010-04-20
US20030131380A1 (en) 2003-07-10
WO2001075084A2 (en) 2001-10-11
DE60127950D1 (de) 2007-05-31
US20070117196A1 (en) 2007-05-24
DK1272642T3 (da) 2007-07-02
ES2283412T3 (es) 2007-11-01
EP1272642A2 (de) 2003-01-08
EP1138771A1 (de) 2001-10-04
JP2003529367A (ja) 2003-10-07
US7148399B2 (en) 2006-12-12
EP1272642B1 (de) 2007-04-18
PT1272642E (pt) 2007-05-31

Similar Documents

Publication Publication Date Title
Emori et al. All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli.
ES2332915T3 (es) Variantes de protasa con multiples sustituciones.
Beg et al. The primary structure of α‐lactalbumin from camel milk
CN101484469B (zh) 生产胰岛素样生长因子-ⅰ的方法
UA89944C2 (ru) Продуцирование высокоманнозных белков в растительных культурах
FI108943B (fi) Menetelmiä seriiniproteaasi-inhibiittorien valmistamiseksi ja menetelmässä käytettävä synteettinen tai eristetty DNA-sekvenssi, yhdistelmävektori sekä bakteeri- tai hiivaisäntäsolu
KITAGAWA et al. Amino Acid Sequence of Copper, Zinc-Superoxide Dimutase from Spinach Leaves
Ambler The amino acid sequence of cytochrome c‐551.5 (Cytochrome c 7) from the green photosynthetic bacterium Chloropseudomonas ethylica
SU1720493A3 (ru) Способ получени штамма SтRертососсUS SaNGUIS, способного секретировать @ -1,3-глюкан-3-глюканогидролазу
Saraste et al. A gene in Paracoccus for subunit III of cytochrome oxidase
UA122856C2 (uk) Варіантний інсектицидний ген ахмі115 та способи його застосування
ATE268384T1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
Anselme et al. Asparaginyl-tRNA synthetase from Escherichia coli has significant sequence homologies with yeast aspartyl-tRNA synthetase
RU2004122621A (ru) Гены и белки синтазы циклопропансодержащих жирных кислот растений и их применение
EP0251730A2 (de) Herstellung von menschlichem Lysozym
Kanaya et al. Comparison of the primary structures of ribonuclease U2 isoforms
ATE360078T1 (de) Mannanase aus kaffee
ZA200102385B (en) Nucleotide sequences coding for the dapC gene and process for the production of L-lysine.
EP0770137A4 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ES2127192T3 (es) Polipeptidos especificos del epididimo y su aplicacion.
Gonnelli et al. Purification and characterization of two leaf polypeptide inhibitors of leaf protease from alfalfa (Medicago sativa)
CA2301902A1 (en) Novel extracellular serine protease
FR2792651A1 (fr) Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations
Morris et al. Kallikrein and renin: molecular biology and biosynthesis
JP2004313169A (ja) 組換え枯草菌

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1272642

Country of ref document: EP

REN Ceased due to non-payment of the annual fee